My Integrated Shield plan premium is increasing; would lowering the cost of my hospital insurance compromise my coverage?

In recent weeks, we've received numerous queries from clients about how to manage the rising premiums of their shield plans. If you're uncertain whether you have the right shield plan or feel that you're overpaying for your coverage, we've outlined key points in this article to help you decide whether downgrading your plan to reduce your premiums is the right choice for you.

iFAST Insurance Team
iFAST Insurance Team13 Nov 2024 5631 Views


The end of the integrated shield (IP) premium freeze on 31 August 2024 has led to the recent IP premium increase. Coupled with other changes, the up to 35% premium increase in MediShield Life from April 2025 to March 2028 may make your hospital insurance premiums even more expensive. This is especially true if you are in the older age group where premiums tend to be even higher. If you are thinking of lowering your premiums by downgrading your plan, but wonder if this will compromise your hospital coverage, this is what we think:


1. If you are on private hospital IP plans,

  • Private hospital IP plans available on FSMOne: Enhanced IncomeShield Preferred, Singlife Shield Plan 1, Raffles Shield Private
  • If you are currently on a private integrated shield plan, ask yourself what is your usual approach when seeking healthcare? Do you have specific doctor or hospital that you prefer to visit or do you go to the A&E or a polyclinic to get a referral for further treatment? If you prefer the former and would like shorter waiting times and private care, then keep your private hospital IP plan. This will ensure that your hospitalisation needs are sufficiently covered.

    However, if you fall into the latter category, you may not actually need a private hospital IP plan. In this case, downgrading your IP plan should not be seen as a compromise as Class A IP plans may better suit your needs while also reducing your IP premiums payable.

    [💡 Did you know that half of patients with IP and rider plans still end up using subsidised public healthcare when hospitalised? If you fall into this group, it is worth reconsidering if your IP and rider coverage is really necessary or if downgrading your coverage plan would be a better option.]

    Key differences between Private hospital and Class A IP plans


    Key differences

    Similarities

    Enhanced IncomeShield Preferred (Private hospital IP) vs Advantage (Class A IP)
  • Annual policy limit and ward entitlement
  • Pre and post-hospitalisation benefits for panel providers
  • Living donor organ transplant benefit
  • Inpatient psychiatric treatment benefit
  • Prosthesis benefit
  • As-charged inpatient hospital treatment
  • Cancer Drug Treatment limit
  • Deductible for each policy year
  • As-charged outpatient hospital treatment
  • Singlife Shield Plan 1 (Private hospital IP) vs Plan 2 (Class A IP)
  • Annual policy limit and ward entitlement
  • Living donor organ transplant
  • Extra inpatient benefit for Critical Illnesses
  • Inpatient psychiatric treatment (after 10 months of continuous cover)
  • As-charged inpatient benefits (including pre and post hospitalisation benefit)
  • Cancer Drug Treatment limit
  • Deductible and co-insurance for each policy year
  • As-charged outpatient hospital treatment
  • Family discount and free new-born benefit
  • List of differences and similarities are for illustration purposes only. Please refer to your policy wording for more information. Information retrieved on 12 November 2024.

    (See: A Guide to assessing your Enhanced IncomeShield plan)

    (See: Assess your Singlife Shield plan with this one guide)


    2. If you are on Class A ward plans,

  • Class A ward plans available on FSMOne: Enhanced IncomeShield Advantage, Singlife Shield Plan 2, Raffles Shield A
  • If you are on Class A ward plans and are comfortable with the premiums, then there is no need to make any changes to your coverage. Keep your existing plans until you feel the need for a review.

    Consider downgrading from a Class A IP only if you are not particular about the type of ward that you seek treatment at. This is because Class A wards are still a comfortable single-bedder air-conditioned ward with attached bathroom and television. By downgrading to other IP plans, individuals will no longer be staying in a private room, rooms may not be air-conditioned and will either come with a shared bathroom or a common bathroom. If you value comfort and privacy, maintaining your Class A IP plan is the best option because a downgrade in IP plan may result in a compromise in your comfort.

    What the different hospital ward classes mean:

  • Class A ward – Single bed, air-conditioned room with attached bathroom and television.
  • Class B1 ward – 4 to 5 bedder air-conditioned room with shared attached bathroom and television.
  • Class B2 ward – 6 bedder room with shared bathroom (bathroom may not be attached to room). Ward may be air-conditioned or fan ventilated.

  • 3. If you are considering a standard IP plan or MediShield Life (MSHL),

    MediShield Life is designed to cover 9 in 10 subsidised bills at public healthcare institutions. If you are content to seek treatment at B2 or C wards in public hospitals, MediShield Life will provide adequate coverage. However, if you are looking to stay at a more comfortable ward class, having a standard IP and/or MSHL alone is not for you.

    While downgrading to a public healthcare IP does not mean a lower quality of care, there are still notable differences in coverage (and possibly comfort levels) between a Private, Class A, and non-standard B1 IP plan as compared to a standard IP plan with B1 ward coverage or MediShield Life.

    If you are looking to downgrade to a standard IP plan or MSHL, take note of these key differences:


    Standard IP (B1 ward) plan, or MediShield Life (MSHL)

    Private, Class A, or non-standard B1 plan

    Coverage offered
    No as-charged coverage
    As-charged coverage
    Pre and post hospitalisation treatment
    Not covered
    Covered
    Cancer treatment coverage
    Fixed rate, or up to 2 or 3x MSHL limit for standard IP
    Higher, up to 5x MSHL limit

    In this instance, downgrading to a standard IP plan or MediShield Life may be a compromise as you would receive less coverage, with the absence of benefits such as as-charged coverage and pre or post hospitalisation coverage.

    (See: MediShield Life coverage is increasing. Do you still need a Shield plan?)


    Have a question? Speak to us about your shield plans here:






    Available Products on FSMOne Insurance

    Term Life, Whole Life, Critical Illness, Annuity, Health, Endowment, General Insurance (Personal and Commercial)


    from AIG, Allianz, Cigna, Chubb, Etiqa Insurance, FWD Insurance, Great Eastern, Henner, Income, Manulife, MSIG, Raffles Health Insurance, Singlife, Sompo, Tokio Marine, and QBE.


    *Please check with our team if the product you want is available on FSMOne Insurance



    Read also,

  • Is private hospital insurance really necessary?
  • Can my Integrated Shield Plan and travel insurance cover the same medical expenses while traveling?
  • 1 in 5 Singaporeans lack life insurance coverage. Are you the 1 in 5?
  • What is hospital cash benefit, and why will I need this?


  • Information obtained from:

    https://www.moh.gov.sg/newsroom/medishield-life-adequacy-and-ip-consumer-education

    https://www.moh.gov.sg/managing-expenses/schemes-and-subsidies/integrated-shield-plans/comparision-of-integrated-shield-plans#2018113316819f1c59cf09bdfe00c805

    Information retrieved on 12 November 2024.



    Disclaimer:

    All materials and content found in this article are strictly for information purposes only and should not be considered as an offer or solicitation to transact in any product. This article is not a contract of insurance.

    Insurance products are underwritten by the respective insurance partners and distributed by iFAST Financial Pte Ltd (“iFAST”). You are advised to review the specific terms, conditions and exclusions in the relevant policy contract.

    You are advised to read the key product documents, including (but not limited to) the product summary, before deciding whether the product is suitable for you. You should consider carefully if the products you are purchasing are suitable for your financial objectives, experience, risk tolerance and other personal circumstances. If you are uncertain about the suitability of a product, please seek advice from a financial adviser before making a decision to purchase the product.

    While iFAST and its third-party providers strive to provide accurate and timely information, there may be inadvertent omissions, inaccuracies, and typographical errors. Opinions expressed herein are subjected to change without notice.

    Purchasing a life insurance policy is a long-term commitment, and early termination may involve significant costs. The surrender value, if any, may be zero or less than the total premiums paid.

    This advertisement has not been reviewed by the Monetary Authority of Singapore.

    All materials and contents found in this site are strictly for general circulation and informational purposes only and should not be considered as an offer, or solicitation, to deal in any of the funds or products found/identified in this site. While iFAST Financial Pte Ltd ("IFPL") has tried to provide accurate and timely information, there may be inadvertent delays, omissions, technical or factual inaccuracies and typographical errors. Any opinion or estimate contained in this report is made on a general basis and neither IFPL nor any of its servants or agents have given any consideration to nor have they or any of them made any investigation of the investment objective, financial situation or particular need of any user or reader, any specific person or group of persons. You should consider carefully if the products you are going to purchase are suitable for your investment objective, investment experience, risk tolerance and other personal circumstances. If you are uncertain about the suitability of the investment product, please seek advice from a financial adviser, before making a decision to purchase the investment product. Past performance is not indicative of future performance. The value of the investment products and the income from them may fall as well as rise. Opinions expressed herein are subject to change without notice. In respect of any matters arising from, or in connection with the said research analyses or research reports, recipients of the report are to contact IFPL at 10 Collyer Quay, #26-01 Ocean Financial Centre Building, Singapore 049315, or by telephone at +65 6557 2853. Where the report contains research analyses or research reports from a foreign research house and if the recipient of such research analyses or research reports is not an accredited investor, expert investor, institutional investor or an ex-accredited investor, IFPL accepts legal responsibility for the contents of such analyses or reports to such persons only to the extent as required by law. Please note that only certain security(ies) herein are available to all investors, while the rest are only available for certain persons to invest in, such as Accredited Investors (as defined in the Securities and Futures Act) or one who invests at least S$200,000 (or its equivalent currency) per transaction. To qualify as an Accredited Investor, one needs to submit a declaration form and certain relevant supporting documents, according to iFAST’s prevailing policies and procedures.

    Please read our full disclaimers on the website at ( https://secure.fundsupermart.com/fsmone/policies/328125/investment-account-terms-&-conditions).

    iFAST Financial Pte Ltd (IFPL) (registered address: 10 Collyer Quay #26-01 Ocean Financial Centre Singapore 049315, Telephone: 6557 2000) holds the Financial Advisers Licence issued by the Monetary Authority of Singapore ('MAS') to conduct regulated activities of advising on securities, marketing of collective investment schemes and arranging of any contract of insurance in respect of life policies, other than a contract of reinsurance and the Capital Markets Services Licence issued by the MAS to conduct regulated activities of dealing in securities and providing custodial services for securities. While IFPL has made every effort to ensure the independence of the report's contents, IFPL's nature of business is such that IFPL and its connected and associated entities together with their respective directors, officers and staff may be involved in providing dealing or investment-related services in the abovementioned securities, and have taken or may take positions in the securities mentioned in this report, and may also act as the principal for any buy or sell trades.